← Back to Clinical Trials
Recruiting NCT07282392

Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Lupus
Sponsor University of Utah
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2025-12-01
Completion 2028-10-15
Interventions
Emotional Awareness and Expression Therapy (EAET)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if a psychotherapy intervention works to relieve widespread pain in patients with lupus. The main questions it aims to answer are: Is the psychotherapy treatment safe for lupus patients? Are lupus patients able to complete the treatment? Can the treatment help improve chronic pain and other symptoms in lupus patients? Researchers will compare the treatment to a control (participants who will continue their medical treatment but will not receive psychotherapy for the time frame of the treatment) to see if the psychotherapy treatment works to relieve widespread pain and other lupus-related symptoms. Participants will: Fill out questionnaires before and after the treatment. Participate in 8 weekly treatment sessions, 2 hours per session, delivered via Zoom from their own home. Keep a list of medications and monitor any changes in their medication regimen.

Eligibility Criteria

Inclusion Criteria: * Adults of all genders, ages 18-65. * A diagnosis of lupus and fibromyalgia or chronic widespread pain by a licensed rheumatologist * Be on a stable medication regimen. Exclusion Criteria: * Serious psychiatric disorders (e.g., schizophrenia or bipolar disorder) uncontrolled with medications. * Active suicidal ideation. * Untreated alcohol or substance use disorder. * Substantial cognitive impairment. * Changes in medications in the past 3 months. * Enrollment in another treatment study. * Current involvement in health-related litigation or disability application. * Inability to use a computer and/or smartphone. * limited access to the internet. * Inability to communicate in English. * Failure to complete the baseline assessments.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}